Position in BMY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,148,807
-$113,247 QoQ
Shares Held
89,358
+3.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#541
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. BMY ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
|
26,087 | $4,088,354 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,148,807 | 89,358 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,262,054 | 86,761 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,613,488 | 85,530 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,682,099 | 81,643 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,680,656 | 79,513 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $4,930,614 | 80,843 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,553,589 | 80,509 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,163,724 | 80,474 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,429,796 | 82,586 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,490,406 | 82,803 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,870,723 | 75,438 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $3,827,679 | 65,949 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $3,780,276 | 59,113 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $3,876,161 | 55,925 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $3,866,017 | 53,732 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $3,801,822 | 53,479 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $3,876,873 | 50,349 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,627,400 | 49,670 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,954,579 | 47,387 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,644,899 | 44,700 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,507,286 | 37,523 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,145,851 | 33,991 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,982,106 | 31,954 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,905,043 | 31,598 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,761,118 | 29,951 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,468,135 | 26,339 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||